Inj, vasopressin (baxter)
Products billed under this code include Vasopressin.
Payment limit per 1 UNIT, by effective quarter, 1Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Vasopressin.
Payment limit per 1 UNIT, by effective quarter, 1Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Vasopressin | Baxter Healthcare Corporation | 00338-9640-12 | 240 | $558.72 |
| Vasopressin | Baxter Healthcare Corporation | 00338-9647-12 | 480 | $1,117.44 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $2.328 | +$0.575 | 1 UNIT | Inj, vasopressin (baxter) | v1, posted September 17, 2026 |
| 3Q26 | $1.753 | +$0.221 | 1 UNIT | Inj, vasopressin (baxter) | v1, posted September 15, 2026 |
| 2Q26 | $1.532 | −$0.69 | 1 UNIT | Inj, vasopressin (baxter) | v1, posted September 15, 2026 |
| 1Q26 | $2.222 | +$0.214 | 1 UNIT | Inj, vasopressin (baxter) | v1, posted September 15, 2026 |
| 4Q25 | $2.008 | −$0.928 | 1 UNIT | Inj, vasopressin (baxter) | v1, posted September 8, 2026 |
| 3Q25 | $2.936 | −$0.565 | 1 UNIT | Inj, vasopressin (baxter) | v1, posted March 10, 2026 |
| 2Q25 | $3.501 | −$0.133 | 1 UNIT | Inj, vasopressin (baxter) | v1, posted March 10, 2026 |
| 1Q25 | $3.634 | – | 1 UNIT | Inj, vasopressin (baxter) | v1, posted December 19, 2025 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.